|
|
|
Insider
Information: |
Bradbury Daniel |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
223,469 |
|
Indirect Shares
|
3,161,475 |
|
|
Direct
Value |
$2,602,212 |
|
|
Indirect Value
|
$3,786,678 |
|
|
Total
Shares |
3,384,944 |
|
|
Total
Value |
$6,388,890 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-06 |
4,655 |
2024-05-06 |
9,981 |
Premium* |
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
423 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 17
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMLN |
Amylin Pharmaceuticals In... |
Executive Vice President |
|
2003-11-24 |
4 |
OE |
$7.13 |
$42,750 |
D/D |
6,000 |
16,194 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-02-06 |
4 |
AS |
$20.05 |
$10,025 |
I/I |
(500) |
7,485 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-02-27 |
4 |
D |
$22.91 |
$16,060 |
I/I |
(701) |
12,691 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-02-27 |
4 |
OE |
$2.72 |
$16,061 |
I/I |
5,907 |
13,392 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-03-05 |
4 |
AS |
$25.30 |
$12,650 |
I/I |
(500) |
12,191 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-04-05 |
4 |
AS |
$23.62 |
$11,810 |
I/I |
(500) |
11,691 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-04-30 |
4 |
OE |
$7.13 |
$46,313 |
I/I |
6,500 |
18,191 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-05-07 |
4 |
AS |
$22.60 |
$11,300 |
I/I |
(500) |
17,691 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-06-07 |
4 |
AS |
$22.63 |
$11,315 |
I/I |
(500) |
17,191 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-07-08 |
4 |
AS |
$22.30 |
$11,150 |
I/I |
(500) |
16,691 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-08-27 |
4 |
D |
$19.88 |
$103,495 |
D/D |
(5,206) |
26,636 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-08-27 |
4 |
OE |
$7.13 |
$103,498 |
D/D |
14,526 |
31,842 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-09-08 |
4 |
AS |
$20.97 |
$20,985 |
I/I |
(1,000) |
15,691 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-10-07 |
4 |
AS |
$20.75 |
$20,750 |
I/I |
(1,000) |
14,691 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-11-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
110 |
14,581 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-11-05 |
4 |
AS |
$23.15 |
$23,150 |
I/I |
(1,000) |
13,581 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-12-07 |
4 |
AS |
$21.45 |
$21,475 |
I/I |
(1,000) |
12,581 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-12-10 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,000 |
10,581 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-12-10 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,000 |
2,000 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2005-01-05 |
4 |
AS |
$22.66 |
$22,660 |
I/I |
(1,000) |
9,581 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2005-02-07 |
4 |
AS |
$23.00 |
$34,500 |
I/I |
(1,500) |
8,081 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2005-04-27 |
4 |
OE |
$7.13 |
$101,132 |
D/D |
14,194 |
41,636 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2005-06-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
100 |
7,981 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2005-07-07 |
4 |
AS |
$20.50 |
$30,750 |
I/I |
(1,500) |
6,481 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2005-08-05 |
4 |
AS |
$20.01 |
$40,020 |
I/I |
(2,000) |
4,481 |
|
- |
|
423 Records found
|
|
Page 1 of 17 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|